Literature DB >> 7792560

Lung cancer containing growth hormone-releasing hormone associated with hypertrophic osteoarthropathy. Case report.

H Nomori1, R Kobayashi, A Kubo, S Morinaga, Y Shintani, T Sano.   

Abstract

In a 49-year-old man, large-cell carcinoma of the lung was accompanied by raised serum levels of growth hormone (GH) and growth hormone-releasing hormone (GHRH) and hypertrophic osteoarthropathy. Immunohistochemically the tumour contained GHRH but not GH. The osteoarthropathy disappeared after resection of the primary tumour and did not reappear after its recurrence. The high serum GH level presumably was due to ectopic GHRH production in the tumour. The hypertrophic osteoarthropathy was not clearly attributable to these hormones.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7792560     DOI: 10.3109/14017439409099120

Source DB:  PubMed          Journal:  Scand J Thorac Cardiovasc Surg        ISSN: 0036-5580


  3 in total

1.  Commentary: octreotide and hypertrophic pulmonary osteoarthropathy.

Authors:  R T Penson; R M Rudd
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

2.  Treatment of resistant pain in hypertrophic pulmonary osteoarthropathy with subcutaneous octreotide.

Authors:  S A Johnson; P A Spiller; C M Faull
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

3.  Hypertrophic pulmonary osteoarthropathy with primary lung cancer.

Authors:  Xinyu Qian; Jing Qin
Journal:  Oncol Lett       Date:  2014-04-02       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.